(Q33395423)

English

Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: a single-institution experience

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: a single-institution experience (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Huiqiang Huang

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Zexiao Lin

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Xubin Lin

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Qingqing Cai

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Zhongjun Xia

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Wenqi Jiang

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

1 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1041-1048

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.561388

21 January 2018

Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.561388

21 January 2018

Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.561388

21 January 2018

Angiocentric T-cell and NK/T-cell lymphomas: radiotherapeutic viewpoints.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.561388

21 January 2018

Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.561388

21 January 2018

CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma?

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.561388

21 January 2018

Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.561388

21 January 2018

Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.561388

21 January 2018

P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.561388

21 January 2018

Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.561388

21 January 2018

Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.561388

21 January 2018

Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.561388

21 January 2018

Autologous hematopoietic stem cell transplantation in extranodal natural killer/T cell lymphoma: a multinational, multicenter, matched controlled study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.561388

21 January 2018

High-dose chemotherapy with autologous stem cell transplantation in extranodal NK/T-cell lymphoma: a retrospective comparison with non-transplantation cases

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.561388

21 January 2018

Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.561388

21 January 2018

Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.561388

21 January 2018

Identifiers

10.3109/10428194.2011.561388

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

release_vuyxn5bzk5eyngkttyje7sy4de

1 reference

https://api.fatcat.wiki/v0/release/vuyxn5bzk5eyngkttyje7sy4de

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33395423&oldid=1836524329"